Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

237.33
Delayed Data
As of Mar 24
 +2.04 / +0.87%
Today’s Change
184.50
Today|||52-Week Range
281.28
+13.01%
Year-to-Date
Can This Pharma Stock Withstand the 'Trump Effect'?
5:04pm / TheStreet.com - Paid Partner Content
The Good, the Bad and the Ugly (Early Afternoon Edition)
Mar 23 / TheStreet.com - Paid Partner Content
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Teva Pharma Denies Rumors of Global Workforce Reduction
Mar 24 / Zacks.com - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
All Eyes On Washington: US Futures Rise On Hope Healthcare Vote Will Pass
Mar 24 / Investing Channel - Paid Partner Content
Adding to AGN Long
Mar 23 / TheStreet.com - Paid Partner Content
The Most Attractive Value Stock There Is?
Mar 23 / GuruFocus News - Paid Partner Content
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close235.29
Today’s open235.35
Day’s range234.86 - 238.35
Volume2,688,552
Average volume (3 months)4,195,071
Market cap$79.6B
Dividend yield1.18%
Data as of 4:00pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.72%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.01+0.03%
ABTAbbott Laboratories-0.04-0.09%
BMYBristol-Myers Squibb+0.12+0.22%
LLYEli Lilly and Co-0.24-0.28%
Data as of 4:03pm ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.39
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs